Propanc Biopharma PPCB
NASDAQ PPCB
$0.51 -0.02 (-3.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Current Debt (2013 - 2014)

Updated

Propanc Biopharma's Current Debt was -$1.00 in fiscal Q4 2014 (quarter ended Jun 30, 2014), compared with -$96.00 a year earlier.

Analysis

Propanc Biopharma (PPCB) Current Debt (2013 - 2014) Analysis & Trends

For FY2014 (ended Jun 30, 2014), Current Debt at Propanc Biopharma came in at -$6.00.

  • In earlier fiscal years, Current Debt was $5.00 in FY2013.
  • Quarterly Current Debt has moved between -$96.00 (fiscal Q4 2013) and $1.00 (fiscal Q2 2014) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Propanc Biopharma 595,565.74 595,565.74 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -1.00
Dec 31, 2013 1.00
Sep 30, 2013 -6.00
Jun 30, 2013 -96.00
API Access

Propanc Biopharma Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEY